Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Common adverse events associated with an SSRI: meta-analysis of early paroxetine data.

Aursnes I, Gjertsen MK.

Pharmacoepidemiol Drug Saf. 2008 Jul;17(7):707-13. doi: 10.1002/pds.1596.

PMID:
18383561
2.

Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

Landén M, Högberg P, Thase ME.

J Clin Psychiatry. 2005 Jan;66(1):100-6.

PMID:
15669895
3.

Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.

Rahimi R, Nikfar S, Abdollahi M.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):118-27. doi: 10.1016/j.pnpbp.2008.10.018. Epub 2008 Nov 12.

PMID:
19028540
4.

Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.

Katzman MA, Tricco AC, McIntosh D, Filteau MJ, Bleau P, Chokka PR, Kjernisted KD, Mok H, Pham B.

J Clin Psychiatry. 2007 Dec;68(12):1845-59. Review.

PMID:
18162015
5.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
6.

SSRI treatment-associated stroke: causality assessment in two cases.

Ramasubbu R.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1197-201. Epub 2004 May 18.

PMID:
15150381
7.

Lower side effects of milnacipran than paroxetine in the treatment of major depression disorder among Han Chinese in Taiwan.

Chang TT, Lêng CH, Wu JY, Lee SY, Wang YS, Chen YC, Lu RB.

Chin J Physiol. 2008 Dec 31;51(6):387-93.

PMID:
19280883
8.

Paroxetine: new indication. In social phobia: minimal assessment.

[No authors listed]

Prescrire Int. 2003 Aug;12(66):137-9.

PMID:
12906023
9.

Suicide attempts in clinical trials with paroxetine randomised against placebo.

Aursnes I, Tvete IF, Gaasemyr J, Natvig B.

BMC Med. 2005 Aug 22;3:14. Review.

10.

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0. Epub 2009 Jan 22.

PMID:
19165525
11.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
12.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

13.

Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD.

J Clin Psychiatry. 2008 Jun;69(6):991-8.

PMID:
18517289
14.

Urticarial vasculitis secondary to paroxetine.

Welsh JP, Cusack CA, Ko C.

J Drugs Dermatol. 2006 Nov-Dec;5(10):1012-4.

PMID:
17373154
15.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
16.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW.

J Clin Psychopharmacol. 2008 Dec;28(6):631-7. doi: 10.1097/JCP.0b013e31818a6cea.

PMID:
19011431
17.

[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].

Van Ermen AM, Ottervanger JP, Roisin T, Kurz X, Stricker BH.

Ned Tijdschr Geneeskd. 1996 Sep 7;140(36):1817-20. Dutch.

PMID:
8927144
18.

Escitalopram in the treatment of major depressive disorder: a meta-analysis.

Kennedy SH, Andersen HF, Thase ME.

Curr Med Res Opin. 2009 Jan;25(1):161-75. doi: 10.1185/03007990802622726 .

PMID:
19210149
19.

Paroxetine: new indication. In generalised anxiety: uncertain efficacy.

[No authors listed]

Prescrire Int. 2003 Oct;12(67):175-7.

PMID:
14619895
20.

Phenytoin as an augmentation for SSRI failures: a small controlled study.

Shapira B, Nemets B, Trachtenberg A, Belmaker RH.

J Affect Disord. 2006 Nov;96(1-2):123-6. Epub 2006 Jun 30.

PMID:
16814397

Supplemental Content

Support Center